PHI with Primary biliary cholangitis (PBC)
How does this condition affect your private health insurance?
Primary Biliary Cholangitis (PBC), previously known as Primary Biliary Cirrhosis, is a chronic autoimmune liver disease. It involves the progressive destruction of small bile ducts within the liver, leading to the accumulation of bile and toxic substances (cholestasis). This chronic inflammation eventually causes fibrosis, and if untreated, can progress to cirrhosis and liver failure. Symptoms often include debilitating fatigue and severe itching (pruritus); jaundice appears in later stages. Predominantly affecting middle-aged women, diagnosis relies on elevated liver enzymes, particularly alkaline phosphatase, and the presence of antimitochondrial antibodies (AMAs). Treatment, primarily with ursodeoxycholic acid, aims to slow disease progression and manage symptoms.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Often asymptomatic for years, then insidious onset of vague symptoms developing over months or even longer.
Duration of Illness (Lifetime)
Chronic, progressive disease, typically lifelong, requiring ongoing management.
Cost of Treatment (Initial)
Moderate (diagnostic tests including blood work, imaging, liver biopsy, initial medication), potentially several thousands of dollars.
Cost of Treatment (Lifetime)
High (lifelong medication, regular monitoring, management of complications, potential liver transplant if end-stage disease develops), ranging from tens of thousands to hundreds of thousands of dollars.
Mortality Rate
Low in early stages with effective treatment; increases significantly with disease progression to liver failure without liver transplantation.
Risk of Secondary Damages
High (cirrhosis, portal hypertension, varices, ascites, hepatic encephalopathy, osteopenia/osteoporosis, malabsorption of fat-soluble vitamins, chronic fatigue, pruritus, psychosocial impact).
Probability of Full Recovery
Very low; PBC is generally considered incurable, but treatment can significantly slow progression and improve quality of life.
Underlying Disease Risk
Moderate to high (PBC is an autoimmune disease often associated with other autoimmune conditions such as Sjögren's syndrome, autoimmune thyroid disease, or rheumatoid arthritis).